Janus Henderson Group PLC Bei Gene, Ltd. Transaction History

Janus Henderson Group PLC

$187 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$121.11 - $216.05 $206,008 - $367,501	-1,701 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$146.52 - $269.56 $249,230 - $458,521	1,701 New	1,701 $321,000
Q4 2021 Feb 14, 2022	SELL	$248.56 - $389.34 $219,229 - $343,397	-882 Closed	0 $0
Q3 2021 Nov 16, 2021	SELL	$249.6 - $403.14 $86,112 - $139,083	-345 Reduced 28.12%	882 $320,000
Q2 2021 Aug 16, 2021	SELL	$292.75 - $367.01 $102,169 - $128,086	-349 Reduced 22.14%	1,227 $421,000
Q1 2021 May 17, 2021	BUY	$260.64 - $382.12 $410,768 - $602,221	1,576 New	1,576 $549,000
Q4 2020 Feb 16, 2021	SELL	$221.31 - $316.61 $21 Million - $30.1 Million	-95,096 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$189.18 - $286.44 $16.8 Million - $25.5 Million	88,928 Added 1441.76%	95,096 $27.2 Million
Q2 2020 Aug 14, 2020	SELL	$123.9 - $195.41 $73,844 - $116,464	-596 Reduced 8.81%	6,168 $1.16 Million
Q1 2020 May 14, 2020	SELL	$121.84 - $173.19 $43.2 Million - $61.4 Million	-354,625 Reduced 98.13%	6,764 $833,000
Q4 2019 Feb 18, 2020	SELL	$115.78 - $208.34 $18.7 Million - $33.6 Million	-161,175 Reduced 30.84%	361,389 $59.9 Million
Q3 2019 Nov 14, 2019	SELL	$120.61 - $148.29 $907,710 - $1.12 Million	-7,526 Reduced 1.42%	522,564 $64 Million
Q2 2019 Jul 31, 2019	BUY	$113.99 - $146.86 $6.55 Million - $8.44 Million	57,466 Added 12.16%	530,090 $65.7 Million
Q1 2019 Apr 30, 2019	SELL	$122.82 - $151.83 $907,516 - $1.12 Million	-7,389 Reduced 1.54%	472,624 $62.4 Million
Q4 2018 Feb 06, 2019	BUY	$107.01 - $175.15 $4.01 Million - $6.57 Million	37,506 Added 8.48%	480,013 $67.3 Million
Q3 2018 Nov 09, 2018	BUY	$152.62 - $189.66 $8.33 Million - $10.4 Million	54,593 Added 14.07%	442,507 $76.2 Million
Q2 2018 Aug 10, 2018	SELL	$152.5 - $216.77 $85.1 Million - $121 Million	-558,250 Reduced 59.0%	387,914 $59.6 Million
Q1 2018 May 14, 2018	BUY	$97.41 - $177.22 $50.5 Million - $91.9 Million	518,841 Added 121.42%	946,164 $159 Million
Q4 2017 Feb 09, 2018	BUY	$79.6 - $114.73 $8.05 Million - $11.6 Million	101,164 Added 31.02%	427,323 $41.8 Million
Q3 2017 Nov 14, 2017	BUY	$66.19 - $103.46 $21.6 Million - $33.7 Million	326,159	326,159 $0

Others Institutions Holding BGNE

# of Institutions

252

Shares Held

45.3M

Call Options Held

292K

Put Options Held

119K

Baker Bros. Advisors LP New York, NY

10.6M
Shares

$1.89 Billion
25.41% of portfolio
Capital International Investors Los Angeles, CA

6.43M
Shares

$1.15 Billion
0.29% of portfolio
Hhlr Advisors, Ltd. Grand Cayman, E9

5.18M
Shares

$927 Million
26.65% of portfolio
Primecap Management CO Pasadena, CA

4.97M
Shares

$891 Million
0.84% of portfolio
Baillie Gifford & CO

3.71M
Shares

$664 Million
0.64% of portfolio

View Full List

About BeiGene, Ltd.

Ticker BGNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,700,000
Market Cap $18.6B
Description
BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...

More about BGNE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.

Account